Drug Discovery & Development

Prostate Cancer Trial Launched for Xofigo
Monthly Prescribing Reference
Bayer HealthCare announced that it has begun enrolling patients into a Phase 3 trial studying Xofigo (radium Ra 223 dichloride) injection in combination with Zytiga (abiraterone acetate; Janssen) and prednisone/prednisolone for the treatment of ...
Bayer Begins To Enroll Patients In Late-stage Trial With Radium-223 DichlorideRTT News
Bayer Launches Phase 3 Prostate Cancer TrialDrug Discovery & Development

all 5 news articles »